These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22608799)

  • 21. Urologic manpower issues for the 21st century: assessing the impact of changing population demographics.
    Weiner DM; McDaniel R; Lowe FC
    Urology; 1997 Mar; 49(3):335-42. PubMed ID: 9123694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chinese urologists' views of practice patterns in the diagnosis and treatment of benign prostatic hyperplasia: a nationwide survey.
    Wu N; Sun J; Yu P; Sun Z
    Int Neurourol J; 2012 Dec; 16(4):191-5. PubMed ID: 23346486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National trends in surgical therapy for benign prostatic hyperplasia in Australia.
    Patel RM; Bariol S
    ANZ J Surg; 2019 Apr; 89(4):345-349. PubMed ID: 30706655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of benign prostatic obstruction: current practice patterns and attitudes in Europe.
    Sosnowski R; De Nunzio C; Ahyai S; Autorino R; Bachmann A; Briganti A; Novara G; Füllhase C; Thiruchelvam N
    Neurourol Urodyn; 2015 Apr; 34(4):395-6. PubMed ID: 25620532
    [No Abstract]   [Full Text] [Related]  

  • 25. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2020.
    Parsons JK; Dahm P; Köhler TS; Lerner LB; Wilt TJ
    J Urol; 2020 Oct; 204(4):799-804. PubMed ID: 32698710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of patients with symptomatic benign prostatic hyperplasia who underwent transurethral resection of the prostate after ineffective alpha-1 blocker treatment by non-urologists].
    Furuya R; Ogura H; Furuya S; Masumori N
    Hinyokika Kiyo; 2006 Feb; 52(2):95-8. PubMed ID: 16541761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
    Nickel JC; Saad F
    Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAG repeat within the androgen receptor gene and incidence of surgery for benign prostatic hyperplasia in U.S. physicians.
    Giovannucci E; Stampfer MJ; Chan A; Krithivas K; Gann PH; Hennekens CH; Kantoff PW
    Prostate; 1999 May; 39(2):130-4. PubMed ID: 10221569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-world therapeutic management and evolution of patients with benign prostatic hyperplasia in primary care and urology in Spain.
    Miñana B; Molero JM; Agra Rolán A; Martínez-Fornes MT; Cuervo Pinto R; Lorite Mingot D; Carreño Á; Palacios-Moreno JM
    Int J Clin Pract; 2021 Aug; 75(8):e14250. PubMed ID: 33884719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical questionnaires about benign prostatic hyperplasia].
    Zhang XH; Li X; Ye ZQ; Sun ZY; Sun YH; Sun G; Wang JY; Na YQ
    Zhonghua Wai Ke Za Zhi; 2008 Aug; 46(15):1153-5. PubMed ID: 19094678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey on the Italian outpatient urologists regarding the management of benign prostatic hyperplasia.
    Magri V; Parazzini F; Chiaffarino F
    Arch Ital Urol Androl; 2006 Mar; 78(1):11-4. PubMed ID: 16752881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States.
    Gee WF; Holtgrewe HL; Albertsen PC; Litwin MS; Manyak MJ; O'Leary MP; Painter MR
    J Urol; 1995 Jul; 154(1):205-6. PubMed ID: 7539861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical procedures for benign prostatic hyperplasia: a nationwide survey in Japan.
    Masumori N; Kamoto T; Seki N; Homma Y;
    Int J Urol; 2011 Feb; 18(2):166-70. PubMed ID: 21272088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The frequency of surgery of benign prostatic hypertrophy].
    Janin P; Haillot O; Boutin JM; Lesourd B; Hubert B; Lanson Y
    Prog Urol; 1995 Sep; 5(4):515-21. PubMed ID: 7581501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisited.
    Juliao AA; Plata M; Kazzazi A; Bostanci Y; Djavan B
    Curr Opin Urol; 2012 Jan; 22(1):34-9. PubMed ID: 22123290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of symptomatic BPH in France: who is treated and how?
    Lukacs B
    Eur Urol; 1999; 36 Suppl 3():14-20. PubMed ID: 10559626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ?
    Miner MM
    Curr Urol Rep; 2009 Jul; 10(4):254-60. PubMed ID: 19570485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term cost comparison between surgical and medical therapy for benign prostatic hyperplasia: a study using hospital billing data.
    Ahn HS; Kim SJ; Choi JB; Choo SH; Shim KH; Kim SI
    BJU Int; 2019 May; 123(5A):E79-E85. PubMed ID: 30303597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.